Table 2

Entry characteristics of children who completed the trial

Placebo group (n=26)Treatment group (n=24)
Values are number (%) or mean (SD).
*p<0.05 (t test).
†Reported eczema or rhinitis excluding wheeze or “asthma” as a diagnosis.
M/F16/1013/11
Age (months)35.6 (8.5)36.2 (10.0)
Recalled symptoms in previous winter
    No of episodes3.5 (1.8)4.2 (6.3)
    Episode duration (days)8.6 (6.0)12.1 (6.3)*
Symptoms between episodes
    Days per month5.0 (4.2)6.2 (4.8)
    Nights per month8.3 (5.1)9.1 (4.1)
Personal atopy†9 (35%)5 (21%)
Parental asthma14 (54%)13 (54%)
Maternal smoking7 (27%)9 (38%)